Weighted-Average Shares Outstanding (Basic): The number of shares held by shareholders including insiders but not including a company's treasury shares, sourced from the company 10-K or 10-Q SEC reports.
Vir Biotechnology, Inc. (VIR) had Weighted-Average Shares Outstanding (Basic) of 138.93M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$0.24M |
|
$-163.14M |
|
$-0.01M |
|
$0.25M |
|
$173.68M |
|
$-173.44M |
|
$10.47M |
|
$-162.97M |
|
$-162.97M |
|
$-163.14M |
|
$-163.14M |
|
$-163.14M |
|
$-163.14M |
|
$-173.44M |
|
$-169.13M |
|
|
Weighted-Average Shares Outstanding (Basic) |
138.93M |
138.93M |
|
$-1.17 |
|
$-1.17 |
|
| Balance Sheet Financials | |
$545.68M |
|
$58.20M |
|
$473.77M |
|
$1.02B |
|
$75.22M |
|
-- |
|
$148.13M |
|
$223.35M |
|
$796.10M |
|
$771.24M |
|
$796.10M |
|
139.02M |
|
| Cash Flow Statement Financials | |
$-365.90M |
|
$223.72M |
|
$2.75M |
|
$318.69M |
|
$179.26M |
|
$-139.44M |
|
$37.87M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.25 |
|
-- |
|
-- |
|
-- |
|
-- |
|
104.58% |
|
-72267.91% |
|
-72267.91% |
|
-- |
|
-67905.42% |
|
-67975.42% |
|
$-370.03M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
-20.49% |
|
-21.15% |
|
-16.00% |
|
-20.49% |
|
$5.73 |
|
$-2.66 |
|
$-2.63 |
|